We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
GUTS

Price
2.14
Stock movement up
+0.01 (1.02%)
Company name
Fractyl Health, Inc. Common Stock
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
70.12M
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-63.60%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-09-12

DIVIDENDS

GUTS does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

FINANCIALS

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.97
Daily high1.02
Daily low0.95
Daily Volume607K
All-time high12.85
1y analyst estimate6.67
Beta-
EPS (TTM)-
Dividend per share-
Ex-div date-
Next earnings date18 Nov 2025

Downside potential

Loading...
Downside potential data
GUTSS&P500
Current price drop from All-time high-92.30%-1.46%
Highest price drop-92.63%-56.47%
Date of highest drop10 Apr 20259 Mar 2009
Avg drop from high-72.95%-10.99%
Avg time to new high195 days12 days
Max time to new high389 days1805 days
COMPANY DETAILS
GUTS (Fractyl Health, Inc. Common Stock) company logo
Marketcap
70.12M
Marketcap category
Small-cap
Description
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
Employees
103
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...